Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and biological characterization of patients with low (0.1-2%) JAK2V617F allele burden at diagnosis

16 May 2014

Abstract excerpt

International audience

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Myeloid Leukemia Treatments
Share to Kruppel-like factors research
Share to Myeloproliferative Neoplasms: Diagnosis and Treatment

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 24837467
DOI: 10.3324/haematol.2014.107656

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and biological characterization of patients with low (0.1-2%) JAK2V617F allele burden at diagnosisPMID 24837467Read ↗

Clinical relevance of JAK2 (V617F) mutant allele burden.Semantic proximity Read ↗

Bone marrow JAK2V617F allele burden and clinical correlates in polycythemia veraSemantic proximity Read ↗

High Risk Janus Kinase 2 V617F Allele Burden in a Seven-Year Cohort of Patients with Myeloproliferative Neoplasms.Semantic proximity Read ↗

JAK2 V617F clonal disorders: fate or chance?Semantic proximity Read ↗

JAK2(V617F) allele burden ⩾50% is associated with response to ruxolitinib in persons with MPN-associated myelofibrosis and splenomegaly requiring therapy.Semantic proximity Read ↗

Considerations for Developing Targeted Therapies in Low-Frequency Molecular Subsets of a Disease.Semantic proximity Read ↗

MPN patients with low mutant JAK2 allele burden show late expansion restricted to erythroid and megakaryocytic lineagesSemantic proximity Read ↗

No Differences in Outcomes Between JAK2 V617F-Positive Patients with Variant Allele Fraction < 2% Versus 2-10%: A 6-Year Province-wide Retrospective Analysis.Semantic proximity Read ↗

JAK2V617F and CALR double mutations are more frequently encountered in patients with low JAK2V617F allelic burdens.Semantic proximity Read ↗

JAK2V617F allele burden, JAK2 46/1 haplotype and clinical features of Chinese with myeloproliferative neoplasmsSemantic proximity Read ↗

JAK2V617F: more than a clonal marker?Semantic proximity Read ↗

Prevalance of JAK2 V617F and exon 12 mutations in polycythaemia veraSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.